Canada Pension Plan Investment Board’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
Other funds holding BPMC
IA
HNB
Canada Pension Plan Investment Board's BPMC Position: Q3 2025 in Review
Canada Pension Plan Investment Board sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 49,400 shares — an estimated $6.33M sold.
Canada Pension Plan Investment Board first reported a position in BPMC in Q4 2019 and held it in 11 quarters. The position peaked at $6.33M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Canada Pension Plan Investment Board reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Canada Pension Plan Investment Board sold 49,400 Blueprint Medicines shares in Q3 2025, an estimated $6.33M.
- Canada Pension Plan Investment Board first reported a position in Blueprint Medicines in Q4 2019 and held it in 11 quarters.
- Canada Pension Plan Investment Board's Blueprint Medicines position peaked at $6.33M in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Canada Pension Plan Investment Board's 13F filing for Q3 2025, filed 13 Nov 2025.